Novo Nordisk Saudi Honored as the Top workplace for Women in 2021

Novo Nordisk Saudi, an affiliate of the global healthcare company with more than 90 years of innovation and leadership in diabetes care, has been recently recognized as the top workplace for women in the Kingdom for the second consecutive year. By creating an inclusive culture, Novo Nordisk Saudi succeeded in giving women the ability to reach their full potential and being represented throughout the workforce and the management.

The recognition is based on an assessment measuring the extent to which women report their organizations create a positive working environment for everyone and how fairly women’s experiences compare to men’s reports of the same workplace. The assessment also factors in the representation of women in the workforce and management, compared to industry trends.

In a statement from Melvin D’Souza, CVP for Novo Nordisk Saudi Arabia commenting on this achievement, he said “Diversity at Novo Nordisk Saudi Arabia is a journey which we embarked over the last couple of years. Female empowerment and recognition of being the front runner in Saudi Arabia again is a testimony of this work.”

Talking about the culture at Novo Nordisk Saudi, Rajiah Meir, Head of HR said “As a diverse team of great talents, we have always put our people at the heart of what we do. In Novo Nordisk Saudi Arabia we are we are all proud to be accredited, for the second year in a row, as the best place to work for women in Saudi Arabia. This reflects our relentless dedication towards female empowerment. Part of living by the Novo Nordisk way is fulfilling that commitment and support our employees in their career progression and help them reach their full potentials. It is, indeed, inspiring to see how Novo Nordisk is investing in emerging female talents based in Saudi Arabia in a mega female leadership-development program.”

“Novo Nordisk Saudi is a great example of high-performance workplace culture that ensures every decision, activity and policy supports the learning, well-being and personal growth of all the female members in the organization” said Hamza Idrissi, Program Manager for Saudi.

Novo Nordisk’s ranking on the top Workplaces for Women list is the latest recognition for Novo Nordisk Saudi as a leading workplace. This year, Novo Nordisk was awarded the top position in the ranking of the Best Places to Work in Saudi for the third consecutive year.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”